GlassScriptPhysician profile
Callie Bowman
NPI 1205133717
$1,311.61
in general payments reported to CMS, 2019-2025
17 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $313 · 2022: $179 · 2023: $322 · 2024: $267 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $513.35 | 2021-2024 | |
| Phathom Pharmaceuticals, INC. | $131.03 | 2024 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $124.27 | 2023 | Fasenra |
| Novo Nordisk INC | $92.13 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Ardelyx, INC. | $60.70 | 2024-2025 | Ibsrela |
| Axsome Therapeutics, INC. | $59.80 | 2025 | Sunosi |
| Bausch Health US, LLC | $54.10 | 2023-2025 | Aplenzin, Wellbutrin |
| Lundbeck LLC | $49.64 | 2024-2025 | Vyepti |
| Takeda Pharmaceuticals U.S.A., INC. | $36.97 | 2021-2025 | Trintellix |
| Phadia US INC. | $31.26 | 2024 | Immunocap |
| Amarin Pharma, INC. | $28.77 | 2021-2022 | |
| Esperion Therapeutics, INC. | $27.94 | 2022-2023 | Nexletol |
| Organon LLC | $25.25 | 2025 | |
| Abbott Laboratories | $24.03 | 2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $23.82 | 2023 | Jardiance, Emgality |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.35 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callie Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.